Prescription-access intelligence corpus

Prescription-access intelligence corpus: plan-specific real-time benefit and coverage rules (what a given payer requires, at what cost, before it will approve a given drug), the PA requirement and formulary-constraint graph per payer-plan-drug triple, submitted case records with approval/denial outcomes and turnaround times, AI-drafted clinical appeal text paired with its overturn outcome, and point-of-prescription coverage/cost predictions with their realized outcomes — plus the underlying prescription and patient clinical context passed through from EHR-integrated workflows

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Develop Health and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: Health Care TechnologyApplication Software
Instruments: equities
Categories: AlternativeReferenceOperational
Regions: US
Sample tickers: LLYNVOUNHELVCVSCAHMCKAZNAMGNHIMS

Dataset card

Type: not stated
Format: Tabular case and transaction records with a structured rules/benefits layer, ingested and emitted through API integrations into EHR and pharmacy workflows (real-time benefit check messages, electronic PA submissions), plus generated free-text clinical appeal documents paired with their adjudication outcomes
Volume: Early-stage but extremely dense per case. Estimate tens of thousands to low hundreds of thousands of prescription-access cases to date (consistent with a 28-person Series A since ~2022 with a small number of named logos), each carrying requirement evaluation, benefit-check response, submission payload, decision, and in denial cases an AI-drafted appeal plus its outcome. Also a compact, high-value derived asset: the payer-plan-drug requirement-and-cost matrix it maintains to make point-of-prescription prediction possible
Users: N/A — B2B workflow software sold to providers, pharmacies, payers and life-sciences companies, no consumer user base. Volume proxy: ~28 staff and a Series A with a named DTC/GLP-1 pharmacy client (Calibrate) imply thousands-to-tens-of-thousands of prescription-access cases handled, not a registered-user population
History: 4 years
Update frequency: not stated
Growth: Active — Series A funded ($16.1M total raised), founding-team build-out still visible in the staffing profile (co-founders plus founding engineers), a current customer testimonial and case study published, and an AI-automation positioning actively extended into appeals and grievances
Launched: not stated
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site

Develop Health has not added their own details yet. Not yet on file:

Dataset
Data dictionary
Coverage
Provenance
Rights & data handling